Image: portal of the mayor and government of Moscow
Russia has started a comparative clinical study of drugs for the treatment of patients with coronavirus. It is reported RIA Novosti with reference to the press service of the Federal medical-biological Agency.
we are Talking about drugs, “Mefloquine”, “Hydroxychloroquine” and “Coledavis”. Tests will be performed only after consent of patients with confirmed coronavirus infection. To engage in clinical research will be in the Federal medical biophysical center named after Burnazyan.
on the Eve of the Federal medical-biological Agency of Russia has developed a treatment regimen in severe coronavirus pneumonia, accompanied by respiratory failure.
In such cases it is proposed to use the drug “Dalargin”. He already was in Russia as a medicine for healing venous ulcers and protect organs and tissues – lungs, liver and pancreas.
last week, the Director of the state scientific center “Vector” Rinat Maksyutov said that clinical trials of a vaccine against coronavirus in Russia will begin before may 11.
He informed that the remedy COVID-19 already tested on mice and ferrets that have managed to develop immunity to COVID-19. Now began the tests on monkeys.
worldwide, according to who, has already recorded more than 1.21 million cases of infection, almost 67,6 thousand people died. In Russia for the last day of new coronavirus infection were infected 1 154. Only in Russia was 7 497 cases of infection.
In the suburbs for the last days recorded 67 new cases COVID-19
see also
the Ministry of health has provided advice to employers on the background of the situation with COVID-19Собянин told about the beginning of telemedicine for patients with Story coronavirus:Coronavirus COVID-19
